You are here » Home » Companies » Company Overview » Medicamen Biotech Ltd

Medicamen Biotech Ltd.

BSE: 531146 Sector: Health care
NSE: N.A. ISIN Code: INE646B01010
BSE 00:00 | 20 Feb 305.65 -1.25
(-0.41%)
OPEN

314.00

HIGH

318.90

LOW

300.50

NSE 05:30 | 01 Jan Medicamen Biotech Ltd
OPEN 314.00
PREVIOUS CLOSE 306.90
VOLUME 1908
52-Week high 555.95
52-Week low 284.00
P/E 27.39
Mkt Cap.(Rs cr) 374
Buy Price 301.00
Buy Qty 35.00
Sell Price 306.00
Sell Qty 200.00
OPEN 314.00
CLOSE 306.90
VOLUME 1908
52-Week high 555.95
52-Week low 284.00
P/E 27.39
Mkt Cap.(Rs cr) 374
Buy Price 301.00
Buy Qty 35.00
Sell Price 306.00
Sell Qty 200.00

Medicamen Biotech Ltd. (MEDICAMENBIOTEC) - Company History

Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company is engaged in manufacture and distribution of medicines. They manufacturer and supply the range of products such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. The company has two manufacturing facilities namely, Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams. The company is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical Fraternity. Medicamen Biotech Ltd was incorporated on December 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries. The vast distribution network with demand for low cost medicines prompted the company to go for own manufacturing facilities. Thus, in the year 1994, a land of 210,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured. In the year 1995, the company was enlisted in Bombay Stock Exchange. In the year 2005, the company installed the second unit in the tax free zone at Haridwar in Uttarakhand, keeping the space with the ever increase in demand and fulfilling the commitment. During the year 2006-07, the company added Analgesic and Anti bacterial, Anti filarial and Anti TB products in its range and done two mega projects of Govt. of India related to Anti filarial and Anti TB drugs. They also supplied Anti bacterial products like Cotrimoxazole and Anti Analgesics like Paracetamol in bulk to their foreign partners. During the year, the company increased the production capacity of Tablets by 600 lakh Nos to 7800 lakh Nos. The second unit in Haridwar became fully operational from April 2007 with ultra modern manufacturing facilities comprises of Non Betalactum Tablets, Capsules, oral liquids & ointments with the production capacity of 4100 lakh Nos, 600 lakh Nos, 6 lakh Litre and 0.30 lakh kg respectively. The company upgraded the Bhiwadi unit with a consolidated cost of more than Rs 2.5 crore under the latest WHO guidelines on CGMP.